MONECO Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
MONECO Advisors's GILD Position: Q1 2026 in Review
MONECO Advisors reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, selling an estimated $17.4K and leaving 3,568 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #307.
MONECO Advisors first reported a position in GILD in Q2 2020 and has held it in 18 quarters since. The position peaked at $599K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- MONECO Advisors held 3,568 shares of Gilead Sciences worth $497K as of Q1 2026.
- MONECO Advisors sold 124 Gilead Sciences shares in Q1 2026, an estimated $17.4K.
- Gilead Sciences made up 0.04% of MONECO Advisors's portfolio in Q1 2026, its #307 holding.
- MONECO Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 18 quarters since.
- MONECO Advisors's Gilead Sciences position peaked at $599K in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.